FULL CPD MODULE
This module will update your knowledge on ovarian and breast cancer genetics, including:
- The reliability of negative genetic testing
- Risk reduction strategies that moderate/high-risk women should consider
- The implications regarding contraception and HRT for women at high or moderate risk
- Who should be considered for chemoprevention or prophylactic mastectomy
- Who would warrant genetic testing for the BRCA1 or BRCA2 gene
Pulse October survey
Take our April 2025 survey to potentially win £200 worth of tokens
